Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Fadi Jouhra
Research Area(s) / Expertise:

Heart Failure

Heart Failure Devices

Cardiomyopathies

Digital Health
Personal History Dr. Jouhra is based in London, where he works in the Department of Cardiology of St George’s University Hospital NHS Foundation Trust. Academic History Dr. Jouhra began his cardiology training at King’s College Hospital in Oct 2011 as a Locum Appointment Trainee for 1 year. During that year, he developed a specialist interest in heart failure and went on to secure a… View more
Yunlong Xia
Research Area(s) / Expertise:

Cardio-oncology

 Job title: Professor
ProfessorYunlong Xia is President of the Cardio-Oncology Committee of the Chinese Society of Cardiology (CSC). He is also Professor of Cardiology atFirst Affiliated Hospital, Dalian Medical University, Dalian, China. He is a member of the American Rhythmic Society (FHRS), and a fellow of the Europen Society of Cardiology (FESC). Prof Xia is Vice Chairman of theYouth Committee of Chinese… View more
Implementation of Non-Steroidal Mineralocorticoid Receptor Antagonists
Author(s): Muthiah Vaduganathan , Added: 1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Dr Muthiah Vaduganathan and Dr David Charytan discuss the practical implementation of non-steroidal mineralocorticoid receptor antagonists to reduce cardiorenal risk. View more

Heart Failure

Prevention & Chronic Conditions
AHA 25: The AI-SCREEN-CA Study
Author(s): Nobuyuki Kagiyama Added: 7 months ago
AHA Scientific Sessions 2025 - Prof Nobuyuki Kagiyama (Juntendo University School of Medicine, Tokyo, JP) joins us to share findings from the AI-SCREEN-CA study investigating whether an artificial intelligence-based software for checking real-world echocardiography can improve the early and accurate detection of hidden cardiac amyloidosis.Findings showed that this AI software identified around 5%… View more

Imaging & Diagnostics

Heart Failure
Research Area(s) / Expertise:
Cardiogenic Shock: Trial Updates and Future Directions
Author(s): Babar Basir, Balimkiz Senman, Jacob E Møller Start date: Aug 02, 2024
In this insightful webinar, Dr Babar Basir (Henry Ford Heart and Vascular Institute, Detroit, MI, US) is joined by Dr Balimkiz Senman (Duke University Hospital, Boston, MA, US) and Prof Jacob Møller (Odense University Hospital, Odense, DE) to delve into the findings of the DanGer Shock trial, recently presented at the American College of Cardiology (ACC) Conference in April 2024. This session… View more

MI/ACS

Heart Failure
Job title: President
Early Intervention and Intensive Management
Author(s): Vijay Chopra , Deepak L Bhatt , George L Bakris , et al Added: 1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Dr Vijay Chopra, Dr Deepak Bhatt, Dr Michelle Wong and Dr George L Bakris discuss early intervention and intensive management for CRM disease. View more

Heart Failure

Prevention & Chronic Conditions
REBOOT-CNIC: Beta-Blockers Show No Benefit Post-MI in Patients with Preserved Ejection Fraction
Added: 9 months ago Source:  Radcliffe Cardiology
The long-standing practice of prescribing beta-blockers after a myocardial infarction (MI) has been re-examined in the contemporary era of reperfusion therapy. New findings from the REBOOT-CNIC trial suggest that for patients with a preserved left ventricular ejection fraction (LVEF), this routine therapy may not provide the expected benefits.¹REBOOT-CNIC was an open-label, randomised trial… View more

Imaging & Diagnostics

MI/ACS